Pleiotropic effects of thyroid hormones: learning from hypothyroidism

Area of Science:

• Endocrinology and Metabolism
• Cardiovascular Physiology
• Renal Physiology

Background:

• Hypothyroidism causes significant metabolic alterations impacting various organ systems.
• Understanding these changes offers insights into fundamental physiopathological mechanisms.
• Thyroid hormones play a crucial role in regulating cardiovascular and renal functions, as well as lipid metabolism.

Purpose of the Study:

• To investigate the protective effects of experimental hypothyroidism against ischemia reperfusion injury in the heart and kidney.
• To explore the role of adenosine receptors in modulating renal function and vascular tone in hypothyroid states.
• To elucidate the impact of hypothyroidism on lipoprotein metabolism and the potential therapeutic implications of thyromimetic drugs.

Main Methods:

• Induction of experimental hypothyroidism in a rat model.
• Assessment of oxidative damage following ischemia reperfusion in cardiac and renal tissues.
• Measurement of glomerular filtration rate and renal vasoconstriction.
• Analysis of vascular tone regulation by adenosine in the aorta.
• Evaluation of plasma lipid profiles (LDL and HDL cholesterol) and related protein expression.

Main Results:

• Hypothyroid rats exhibited protection against cardiac and renal oxidative stress, linked to pore permeability changes.
• Glomerular filtration rate was reduced in hypothyroid kidneys due to adenosine receptor-mediated vasoconstriction.
• Thyroid hormones influenced aortic vascular tone regulation by adenosine.
• Hypothyroidism led to elevated LDL cholesterol due to reduced hepatic LDL receptor expression.
• HDL cholesterol levels were variable, with altered expression of HDL-related proteins.

Conclusions:

• Experimental hypothyroidism provides a model to understand ischemia reperfusion injury mechanisms.
• Adenosine receptor signaling is critical in hypothyroid-induced changes in renal and vascular function.
• Thyroid hormone-mediated regulation of lipoprotein metabolism highlights the therapeutic potential of thyromimetics for dyslipidemias.